SNS Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-8,900
Closed -$1.32M – 219
2020
Q3
$1.32M Buy
+8,900
New +$1.38M 0.21% 67
2020
Q2
– Sell
-9,700
Closed -$1.35M – 209
2020
Q1
$1.35M Sell
9,700
-1,100
-10% -$151K 0.26% 72
2019
Q4
$1.42M Buy
+10,800
New +$1.25M 0.25% 65

Other funds holding LLY

SNS Financial Group's LLY Position: Q2 2026 in Review

SNS Financial Group increased its Eli Lilly (LLY) stake by 2,931% in Q2 2026, buying an estimated $46.3M and bringing the position to 46,863 shares worth $56.2M. The position accounts for 1.08% of the portfolio, ranked #23.

SNS Financial Group first reported a position in LLY in Q2 2015 and has held it in 27 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SNS Financial Group held 46,863 shares of Eli Lilly worth $56.2M as of Q2 2026.
  • SNS Financial Group bought 45,317 Eli Lilly shares in Q2 2026, an estimated $46.3M.
  • Eli Lilly made up 1.08% of SNS Financial Group's portfolio in Q2 2026, its #23 holding.
  • SNS Financial Group first reported a position in Eli Lilly in Q2 2015 and has held it in 27 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SNS Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.